Ketoconazole for prostate cancer mechanism

Ketoconazole is a nonselective steroid 17α-hydroxylase/17,20 lyase (CYP17A1) inhibitor that has been used, off-label, as a. We report a case of prostatic cancer in which ketoconazole resulted in rapid and sustained reduction in serum androgens as well as rapid induction of a

2024-03-29
    2 milligrams of loperamide
  1. Ketoconazole is a
  2. 2011 ]
  3. Although
  4. The zona fasciculata and reticularis additionally express CYP17A
  5. The therapeutic effect of AAWD